English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 27 Help

Selected(0)Clear Items/Page:    Sort:
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort Journal article
Tang, Liang Jie, Sun, Dan Qin, Song, Sherlot Juan, Yip, Terry Cheuk Fung, Wong, Grace Lai Hung, Zhu, Pei Wu, Chen, Sui Dan, Karsdal, Morten, Leeming, Diana Julie, Jiang, Pei, Wang, Cong, Chen, Qiang, Byrne, Christopher D., Targher, Giovanni, Eslam, Mohammed, George, Jacob, Wong, Vincent Wai Sun, Zheng, Ming Hua. Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort[J]. Liver International, 2024, 44(5), 1129-1141.
Authors:  Tang, Liang Jie;  Sun, Dan Qin;  Song, Sherlot Juan;  Yip, Terry Cheuk Fung;  Wong, Grace Lai Hung; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:6.0/6.3 | Submit date：2024/05/16
Chronic Kidney Disease  Liver Fibrosis  Metabolic Dysfunction-associated Fatty Liver Disease  Metabolic Dysfunction-associated Steatotic Liver Disease  N-terminal Propeptide Of Type 3 Collagen  Risk Prediction  
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12 Journal article
Li, Licen, Zeng, Jianming, Zhang, Xin, Feng, Yangyang, Lei, Josh Haipeng, Xu, Xiaoling, Chen, Qiang, Deng, Chu Xia. Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12[J]. EMBO Reports, 2024, 25(3), 1361-1386.
Authors:  Li, Licen;  Zeng, Jianming;  Zhang, Xin;  Feng, Yangyang;  Lei, Josh Haipeng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.5/8.3 | Submit date：2024/04/02
Fatty Liver  Lipid Homeostasis  Liver Cancer  Serpina12  Sirt6  
Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin Journal article
Xu, Hongling, Yuan, Mingming, Niu, Kailin, Yang, Wei, Jiang, Maoyuan, Zhang, Lei, Zhou, Jing. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin[J]. Molecules, 2024, 29(5), 976.
Authors:  Xu, Hongling;  Yuan, Mingming;  Niu, Kailin;  Yang, Wei;  Jiang, Maoyuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.2/4.6 | Submit date：2024/04/02
Bile Acid  Farnesoid x Receptor  Gut Microbiota  Metabolism-associated Fatty Liver Disease  Nobiletin  
SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice Journal article
Ren, Zhitao, Xiao, Gemin, Chen, Yixin, Wang, Linli, Xiang, Xiaoxin, Yang, Yi, Wen, Siying, Xie, Zhiyong, Luo, Wenhui, Li, Guowei, Zheng, Wenhua, Qian, Xiaoxian, Hai, Rihan, Yang, Liansheng, Zhu, Yanhua, Cai, Mengyin, Ye, Yinong, Shi, Guojun, Chen, Yanming. SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice[J]. Chinese Journal of Natural Medicines, 2023, 21(11), 830-841.
Authors:  Ren, Zhitao;  Xiao, Gemin;  Chen, Yixin;  Wang, Linli;  Xiang, Xiaoxin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.0/3.7 | Submit date：2023/12/18
Non-alcoholic Fatty Liver Disease  Mitochondrial Biogenesis  Traditional Chinese Medicine  Lipid Metabolism  Obesity  Clinical Observation  
Molecular mechanisms of autophagy and implications in liver diseases Journal article
Wu,Yuankai, Tan,Hayden Weng Siong, Lin,Jin Yi, Shen,Han Ming, Wang,Haihe, Lu,Guang. Molecular mechanisms of autophagy and implications in liver diseases[J]. Liver Research, 2023, 7(1), 56-70.
Authors:  Wu,Yuankai;  Tan,Hayden Weng Siong;  Lin,Jin Yi;  Shen,Han Ming;  Wang,Haihe; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:2.0/0 | Submit date：2023/08/03
Acetaminophen (Apap)  Alcohol-related Liver Disease (Arld)  Autophagy  Hepatocellular Carcinoma (Hcc)  Non-alcoholic Fatty Liver Disease (Nafld)  Viral Hepatitis  
Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment Journal article
Chun‑Yong Sun, Le‑Le Yang, Pan Zhao, Pei‑Zheng Yan, Jia Li, Dong‑Sheng Zhao. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment[J]. HEREDITAS, 2022, 159(1), 44.
Authors:  Chun‑Yong Sun;  Le‑Le Yang;  Pan Zhao;  Pei‑Zheng Yan;  Jia Li; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:2.1/2.6 | Submit date：2023/01/30
Cynarine  Non‑alcoholic Fatty Liver Disease  Network Pharmacology  Integration Analysis  Molecular Docking  
Missing-view completion for fatty liver disease detection Journal article
Qi Zhang, Jie Wen, Jianhang Zhou, Bob Zhang. Missing-view completion for fatty liver disease detection[J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 150, 106097.
Authors:  Qi Zhang;  Jie Wen;  Jianhang Zhou;  Bob Zhang
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:7.0/6.7 | Submit date：2022/12/01
Fatty Liver  Missing-view Completion  Facial Image  Tongue Image  Sublingual Image  Noninvasive Disease Detection  
N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD Journal article
Liang‑Jie Tang, Gang Li, Mohammed Eslam, Pei‑Wu Zhu, Sui‑Dan Chen, Howard Ho‑Wai Leung, Ou‑Yang Huang, Grace Lai‑Hung Wong, Yu‑Jie Zhou, Morten Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Hai‑Yang Yuan, Christopher D. Byrne, Giovanni Targher, Jacob George, Vincent Wai‑Sun Wong, Ming‑Hua Zheng. N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD[J]. Hepatology International, 2022, 17, 190–201.
Authors:  Liang‑Jie Tang;  Gang Li;  Mohammed Eslam;  Pei‑Wu Zhu;  Sui‑Dan Chen; et al.
Favorite | TC[WOS]:10 TC[Scopus]:9  IF:5.9/6.6 | Submit date：2023/01/30
Metabolic Dysfunction-associated Fatty Liver Disease  Steatohepatitis  Sequential Algorithm  Fibrosis Staging  
Multi-feature representation for fatty liver disease detection with breath sample analysis Conference paper
Zhang, Qi, Zhou, Jianhang, Zhang, Bob. Multi-feature representation for fatty liver disease detection with breath sample analysis[C], 2022, 3908-3910.
Authors:  Zhang, Qi;  Zhou, Jianhang;  Zhang, Bob
Favorite | TC[Scopus]:1 | Submit date：2023/03/06
Breath Sample  Disease Detection  E-nose  Fatty Liver Disease  Multiple Features  
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Li, Qiao Ping, Dou, Yao Xing, Huang, Zi Wei, Chen, Han Bin, Li, Yu Cui, Chen, Jian Nan, Liu, Yu Hong, Huang, Xiao Qi, Zeng, Hui Fang, Yang, Xiao Bo, Su, Zi Ren, Xie, Jian Hui. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats[J]. Phytomedicine, 2021, 85, 153550.
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui; et al.
Favorite | TC[WOS]:34 TC[Scopus]:36  IF:6.7/6.2 | Submit date：2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine